Danaher Corporation (BMV:DHR)

Market Cap	2.63T -26.7%
Revenue (ttm)	442.30B +2.9%
Net Income	65.06B -7.3%
EPS	90.91 -4.5%
Shares Out	n/a
PE Ratio	40.45
Forward PE	25.43
Dividend	24.18 (0.65%)
Ex-Dividend Date	Dec 26, 2025

Volume	672
Average Volume	1,034
Open	3,660.00
Previous Close	3,751.50
Day's Range	3,660.00 - 3,750.00
52-Week Range	3,358.00 - 4,423.15
Beta	0.96
RSI	36.15
Earnings Date	Jan 28, 2026

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for man...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1969
• Employees: 60,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: DHR

Financial Performance

In 2025, Danaher's revenue was $24.57 billion, an increase of 2.90% compared to the previous year's $23.88 billion. Earnings were $3.61 billion, a decrease of -7.31%.

Financial numbers in USD